WP2 Combined effect of charged particles irradiation and anticancer drugs in cultured human tumor cells (Milano and Roma 3, collaboration with CNAO and.

Slides:



Advertisements
Similar presentations
Understand broad treatment strategies in the treatment of tumors.
Advertisements

Skin Plasma Kidneys Liver B B B ox PB-Alb O2O2 1O21O2 + PB B ox PB Process 2 Process 1 O2O2 Urine Bile- intestine B = bilirubinAlb = albumin PB.
21th WCC, Shenzhen, China, Aug 19, 2010 Guo-Liang Jiang, MD, FACR Min Fan, MD, Jiayan Chen, MD Fudan University Shanghai Cancer Center Combination of radiation.
Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.
4-Dimensional Treatment Planning of Lung Tumors. Lung Cancer 1 out of 14 people will be diagnosed with lung cancer at some point in their life! 90% of.
Characterization of a potential new drug in cancer therapy Lab 2 Salah Farag.
TRAINING COURSE ON RADIATION DOSIMETRY: Radiobiology Basics – RBE, OER, LET Anthony WAKER University of Ontario Institute of Technology Thu. 22/11/2012,
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel.
Dr. Rico Liu Consultant, Department of Clinical Oncology, Queen Mary Hospital Honorary Clinical Associate Professor, Department of Clinical Oncology, The.
New insights into the mechanisms of action of microtubule targeting agents that are effective against metastatic breast cancer Susan L. Mooberry, Ph.D.
Proton Therapy for Chondrosarcomas of the Skull Base and Cervical Spine: Long-term Experience at Loma Linda University Medical Center D. Y. Kim 2, R. W.
H. Koivunoro1, E. Hippelänen1, I. Auterinen2, L. Kankaanranta3, M
Multimodality Therapy Nic Denko Radiation Biology 2011.
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
First Year Workshop 2014 Miriam Lafiandra
Bragg Peak By: Megan Whitley. Bragg Peak  Bragg Peak is the characteristic exhibited by protons that makes them SO appealing for cancer treatment. 
The Increased Biological Effectiveness of Heavy Charged Particle Radiation: From Cell Culture Experiments to Biophysical Modelling Michael Scholz GSI Darmstadt.
Dose distribution assessment in human eye proton therapy by Monte Carlo method 1 Department of Physics, Faculty of Science, University of Isfahan, Isfahan,
Isosteviol derivatives induced apoptosis in Human lung cancer via targeting MEK/MAPK pathway: An in vitro and in vivo study Ahmed M Malki 1,,PhD Stephen.
Chapter 23 Spring 2005 Presented by: Tiffany Marie Thoren Molecular Cell Physiology Dr. James Enderby Bidlack Cancer.
Superiority of 160 kV vs 6 MV X- ray irradiation combined with heavy element radiosensitization By: Sara N. Lim, Anil K. Pradhan, Sultana N. Nahar, Rolf.
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel.
USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.
Basic Biologic Interactions of Radiation IONIZATION.
Regulating the Cell Cycle Page 250 & of the cells in your body will be replaced with new cells, all while you read this sentence.
INTERGROUP STUDY 0148 BMS CA Effect of TAXOL® (paclitaxel) and Doxorubicin Dose on Disease Free and Overall Survival of Patients with Node Positive.
AD-4 Status Report 2013 Biological Effects of Antiprotons Are Antiprotons a Candidate for Cancer Therapy? Additional ontributions to phase two: University.
Combined effect of charged particles irradiation and anticancer drugs in cultured tumor cells.(Milano and Roma 3 RDH_IRPT WP2) Combined radiochemotherapy.
BNCT, a binary radiotherapy at cellular level
MELATONIN SENSITIZES HUMAN BREAST CANCER CELLS TO IONIZING RADIATION DEPARTMENT OF PHYSIOLOGY AND PHARMACOLOGY UNIVERSITY OF CANTABRIA, SANTANDER, SPAIN.
WP2. Combined effect of charged particles irradiation and anticancer drugs in cultured human tumor cells (Milano and Roma 3, collaboration with CNAO and.
1 NANO AMPLIFIED THERAPY INFN-Milano, INFN-Torino, INFN-Pisa, INFN- Roma3, CNR-Pisa, University of Torino - Biotechnology Department.
Rad T 110 Sherer Biologic Effects of Radiation Exposure.
12 th Annual CTOS Meeting 2006 SINGLE AGENT DOXORUBICIN VS DOSE INTENSIVE COMBINATION THERAPY WITH EPIRUBICIN / IFOSFAMIDE IN PREVIOUSLY UNTREATED ADULT.
RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016.
Combined effect of charged particles irradiation and anticancer drugs in cultured tumor cells.(RDH_IRPT WP2; INFN_Milano, CNAO and Istituto Tumori) The.
Therapy-Resistant Cancer Stem Cells Have Differing Sensitivity to Photon versus Proton Beam Radiation  Xiaochun Zhang, MD, Steven H. Lin, MD, PhD, Bingliang.
DNA content flow cytometric histograms of propidium iodide–stained A549 cells. DNA content flow cytometric histograms of propidium iodide–stained A549.
IDH1 mutant glioma cells are sensitive to TMZ
Figure 6 Double opposed-field irradiation of an idealized geometry
Therapy-Resistant Cancer Stem Cells Have Differing Sensitivity to Photon versus Proton Beam Radiation  Xiaochun Zhang, MD, Steven H. Lin, MD, PhD, Bingliang.
A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer  Steven.
Krop I et al. SABCS 2009;Abstract 5090.
Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,
The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death  Kwang Woon Kim, PhD, Christina K. Speirs,
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis
Figure 3 Clinical trial design in charged-particle therapy (CPT)
Figure 2 Host immune responses, not the radiosensitivity
Volume 130, Issue 3, Pages (September 2013)
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer  Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression  Toran Sanli,
Volume 9, Issue 6, Pages (December 2017)
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and.
On the Design of Combination Cancer Therapy
Figure 3 Craniospinal irradiation proton therapy for medulloblastoma
Nanoparticles for enhancing the effectiveness of proton therapy
A B C D Supplementary Figure S1 UMSCC1 Plateau: 24 hr Pre-Treatment
The response of EBT3 films
PX-478 directly radiosensitizes tumor cells in vitro.
Radiosensitization by combined Wee1 and PARP inhibition.
The effects of IAA and glycyrrhizin (Gc) on proliferation and cell-cycle distribution. The effects of IAA and glycyrrhizin (Gc) on proliferation and cell-cycle.
Time course of a G2-M arrest in response to 6-TG compared with IR and VP-16, showing that 6-TG induced a delayed G2-M arrest in MMR+ cells. Time course.
A protracted ketogenic diet increases radiation response in H292 lung cancer xenografts given conventional fractionated radiation. A protracted ketogenic.
WP1066 inhibits the progression of OCIM2 cells through the cell cycle.
BEZ235 inhibits DNA-PK and enhances G2–M growth arrest after radiation
CDV potentiates the antitumor effect of ionizing radiation in mice intracerebrally implanted with human glioblastoma cells. CDV potentiates the antitumor.
Principles of Radiation Therapy
Presentation transcript:

WP2 Combined effect of charged particles irradiation and anticancer drugs in cultured human tumor cells (Milano and Roma 3, collaboration with CNAO and Istituto Tumori_Mi) to improve locoregional tumor control and to reduce distant failure for radioresistant and invasive tumors to reduce the total treatment Dose in radiosensitive patients RDH_IRPT Meeting Roma 24 april 2015

Epothilone B, Microtubule Stabilizing Agent (MSA) At the present used for chemotherapic treatments : fewer side effects, superior pharmacological and anticancer activity, compared with previous MSA (taxanes). Defective mitotic spindle formation, cell cycle arrest in M phase, apoptosis or post mitotic death. Accumulation of cells in the most radiosensitive G2-M phase of the cell cycle. Cell lines: A549 (Non-Small Cell Lung Cancer) very frequent tumor in adults, leading cause of cancer related death in Europe U251MG (glioblastoma) the most aggressive primary malignant brain tumor in adults DAOY (medulloblastoma) the most common malignant brain tumor of childhood End Point: Clonogenic survival and growth curves of the tumor cells irradiated with proton, carbon-ion and photon therapeutic beams, combined or not with Epothilone B RDH_IRPT Meeting Roma 24 april 2015

Determination of Epothilone B concentration for each cell line For equitoxicity in the various cell lines: A2549  nM DAOY  nM U251MG  nM Clonogenic survival of A549 cells vs. Epothilone B concentration

24 h Irradiation at ½ S.O.B.P. (dose range = 0÷5 Gy) Incubation 37°C, 5% CO 2, 90% humidity) 15 days Clonogenic survival vs. Radiation dose/type +/- Epothilone B MEASUREMENTS WITH PROTON BEAMS Samples irradiated with charged particles at CNAO in Pavia + Epothilone B

Results U251MG cells, protons +/- Epothilone B (4 independent exps) Interaction between protons and Epothilone B: Luttjeboer M. et al (2010) Soverl.( D rad + Chem.) = exp(-  D* -  D* 2 ) D * = (D equiv + D rad ) S( D equiv )=S(Chem) D equiv = 1.5 Gy S(Chem) = 0.38 Sindep.(D rad +Chem.) = S(Chem)xS( D rad ) RDH_IRPT Meeting Roma 24 april 2015

U251MG cells, photons +/- Epothilone B (0.125 nM) (4 independent exps)

A549 cells, protons +/- Epothilone B (4 independent exps) RDH_IRPT Meeting Roma 24 april 2015

A549 cells, 6 MV photons +/- Epothilone B (4 independent exps)

DAOY cells, protons +/- Epothilone B (4 independent exps) RDH_IRPT Meeting Roma 24 april 2015

Measurements with photons to be done DAOY 2 independent exps 1-2 more exps to be performed preliminary results similar to those of protons RDH_IRPT Meeting Roma 24 april 2015

U251MG cells, protons and photons (4 independent exps) Protons RBE : RBE 2Gy,  = 1.5 +/- 0.2 RBE 10% = 1.5 +/- 0.2 A549 cells, protons and photons (4 independent exps) Protons RBE : RBE 2Gy,g = 1.5 +/- 0.2 RBE 10% = 1.4 +/- 0.2

Epothilone B effects on cells cycle.. Just started :: Citofluorimetric analysis to measure Epothilone B effects on cells cycle. Data are shown for untreated cells In progress: analysis of samples treated with Epothilone B for 24 h and fixed at various times between 0 and 24 h Daoy A549 U251MG RDH_IRPT Meeting Roma 17 december 2014

To complete experiments with photons Carbon Ions ( 12 C 6+ ) +/- Epothilone B 3 cell lines Citofluorimetric analysis to measure Epothilone B effects on cells cycle 3 cell lines Epothilone B toxicity in cells from normal tissues Next Future